Bacteroides: The good, the bad, and the nitty-gritty

Clinical Microbiology Reviews

Volumn 20, Issue 4, 2007, Pages 593-621

  Wexler, Hannah M ^a,b,c  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Wadsworth Anaerobe Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFOTETAN; CEFOXITIN; CEFTRIAXONE; CHLORAMPHENICOL; CLINAFLOXACIN; CLINDAMYCIN; DORIPENEM; DX 619; ERTAPENEM; GARENOXACIN; IMIPENEM; LEVOFLOXACIN; LINCOSAMIDE DERIVATIVE; LINEZOLID; MACROLIDE; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; NITROIMIDAZOLE DERIVATIVE; PENICILLIN G; QUINOLONE DERIVATIVE; SITAFLOXACIN; SULTAMICILLIN; TICARCILLIN; TIGECYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL METABOLISM; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTEROIDES; BACTEROIDES FRAGILIS; BACTEROIDES THETAIOTAOMICRON; CARBOHYDRATE METABOLISM; COMMENSAL; IMMUNE RESPONSE; INTESTINE FLORA; NONHUMAN; REVIEW;

ADULT; ANTI-BACTERIAL AGENTS; BACTEROIDES; BACTEROIDES FRAGILIS; BACTEROIDES INFECTIONS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; GASTROINTESTINAL TRACT; HUMANS; INFANT; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; VIRULENCE;

BACTEROIDES; BACTEROIDES FRAGILIS;

EID: 35448985445     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.00008-07     Document Type: Review

References (310)

1. Abi, K. G., H. Awada, and R. Nasnas. 2001. Isolated septic arthritis of a lumbar facet joint. J. Med. Liban. 49:228-230.
2. Anderson, K. L., and A. A. Salyers. 1989. Genetic evidence that outer membrane binding of starch is required for starch utilization by Bacteroides thetaiotaomicron. J. Bacteriol. 171:3199-3204.
3. Anderson, K. L., and A. A. Salyers. 1989. Biochemical evidence that starch breakdown by Bacteroides thetaiotaomicron involves outer membrane starch-binding sites and periplasmic starch-degrading enzymes. J. Bacteriol. 171:3192-3198.
4. Aucher, P., J. P. Saunier, G. Grollier, M. Sebald, and J. L. Fauchere. 1996. Meningitis due to enterotoxigenic Bacteroides fragilis. Eur. J. Clin. Microbiol. Infect. Dis. 15:820-823.
5. Avelar, K. E., L. J. Pinto, L. C. Antunes, L. A. Lobo, M. C. Bastos, R. M. Domingues, and M. C. Ferreira. 1999. Production of bacteriocin by Bacteriodes fragilis and partial characterization. Lett. Appl. Microbiol. 29:264-268.
6. Ayala, J., A. Quesada, S. Vadillo, J. Criado, and S. Piriz. 2005. Penicillin-binding proteins of Bacteroides fragilis and their role in the resistance to imipenem of clinical isolates. J. Med. Microbiol. 54:1055-1064.
7. Babu, M. M., M. L. Priya, A. T. Selvan, M. Madera, J. Gough, L. Aravind, and K. Sankaran. 2006. A database of bacterial lipoproteins (DOLOP) with functional assignments to predicted lipoproteins. J. Bacteriol. 188: 2761-2773.
8. Backhed, F., R. E. Ley, J. L. Sonnenburg, D. A. Peterson, and J. I. Gordon. 2005. Host-bacterial mutualism in the human intestine. Science 307:1915-1920.
9. Bajzer, M., and R. J. Seeley. 2006. Physiology: obesity and gut flora. Nature 444:1009-1010.
10. Bamba, T., H. Matsuda, M. Endo, and Y. Fujiyama. 1995. The pathogenic role of Bacteroides vulgatus in patients with ulcerative colitis. J. Gastroenterol. 30(Suppl. 8):45-47.
11. Bamias, G., A. Okazawa, J. Rivera-Nieves, K. O. Arseneau, S. A. De La Rue, T. T. Pizarro, and F. Cominelli. 2007. Commensal bacteria exacerbate intestinal inflammation but are not essential for the development of murine ileitis. J. Immunol. 178:1809-1818.
12. Basset, C., J. Holten, A. Bazeos, D. Vaira, and S. Bloom. 2004. Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Dig. Dis. Sci. 49:1425-1432.
13. Baughn, A. D., and M. H. Malamy. 2004. The strict anaerobe Bacteroides fragilis grows in and benefits from nanomolar concentrations of oxygen. Nature 427:441-444.
14. Baumann, H., A. O. Tzianabos, J. R. Brisson, D. L. Kasper, and H. J. Jennings. 1992. Structural elucidation of two capsular polysaccharides from one strain of Bacteroides fragilis using high-resolution NMR spectroscopy. Biochemistry 31:4081-4089.
15. Beena, V. K., and P. G. Shivananda. 1997. In vitro adhesiveness of Bacte roides fragilis group in relation to encapsulation. Indian J. Med. Res. 105:258-261.
16. Begley, M., C. G. Gahan, and C. Hill. 2005. The interaction between bacteria and bile. FEMS Microbiol. Rev. 29:625-651.
17. Begley, M., C. Hill, and C. G. Gahan. 2006. Bile salt hydrolase activity in probiotics. Appl. Environ. Microbiol. 72:1729-1738.
18. Behra-Miellet, J., L. Calvet, and L. Dubreuil. 2004. A Bacteroides thetaiotamicron porin that could take part in resistance to beta-lactams. Int. J. Antimicrob. Agents 24:135-143.
19. Behra-Miellet, J., L. Calvet, F. Mory, C. Muller, M. Chomarat, M. C. Bezian, S. Bland, M. E. Juvenin, T. Fosse, F. Goldstein, B. Jaulhac, and L. Dubreuil. 2003. Antibiotic resistance among anaerobic Gram-negative bacilli: lessons from a French multicentric survey. Anaerobe 9:105-111.
20. Bendtsen, J. D., T. T. Binnewies, P. F. Hallin, T. Sicheritz-Ponten, and D. W. Ussery. 2005. Genome update: prediction of secreted proteins in 225 bacterial proteomes. Microbiology 151:1725-1727.
21. Bennion, R. S., E. J. Baron, J. E. Thompson, Jr., J. Downes, P. Summanen, D. A. Talan, and S. M. Finegold. 1990. The bacteriology of gangrenous and perforated appendicitis - revisited. Ann. Surg. 211:165-171.
22. Berg, J. O., L. Lindqvist, G. Andersson, and C. E. Nord. 1983. Neuraminidase in Bacteroides fragilis. Appl. Environ. Microbiol. 46:75-80.
23. Bergan, T. 1983. Anaerobic bacteria as cause of infections in female genital organs. Scand. J. Gastroenterol. Suppl. 85:37-47.
24. Betriu, C., E. Culebras, M. Gomez, I. Rodriguez-Avial, and J. J. Picazo. 2005. In vitro activity of tigecycline against Bacteroides species. J. Antimicrob. Chemother. 56:349-352.
25. Betriu, C., I. Rodriguez-Avial, M. Gomez, E. Culebras, and J. J. Picazo. 2005. Changing patterns of fluoroquinolone resistance among Bacteroides fragilis group organisms over a 6-year period (1997-2002). Diagn. Microbiol. Infect. Dis. 53:221-223.
26. Bisharat, N., L. Goldstein, R. Raz, and M. Elias. 2001. Gram-negative anaerobic endocarditis: two case reports and review of the literature. Eur. J. Clin. Microbiol. Infect. Dis. 20:651-654.
27. Bjursell, M. K., E. C. Martens, and J. I. Gordon. 2006. Functional genomic and metabolic studies of the adaptations of a prominent adult human gut symbiont, Bacteroides thetaiotaomicron, to the suckling period. J. Biol. Chem. 281:36269-36279.
28. Boquet, P., P. Munro, C. Fiorentini, and I. Just. 1998. Toxins from anaerobic bacteria: specificity and molecular mechanisms of action. Curr. Opin. Microbiol. 1:66-74.
29. Borer, A., G. Weber, K. Riesenberg, F. Schlaeffer, and J. Horowitz. 1997. Septic arthritis due to Bacteroides fragilis after pilonidal sinus resection in a patient with rheumatoid arthritis. Clin. Rheumatol. 16:632-634.
30. Brazier, J. S., S. L. Stubbs, and B. I. Duerden. 1999. Metronidazole resistance among clinical isolates belonging to the Bacteroides fragilis group: time to be concerned? J. Antimicrob. Chemother. 44:580-581. (Letter.)
31. Brigham, C. J., and M. H. Malamy. 2005. Characterization of the RokA and HexA broad-substrate-specificity hexokinases from Bacteroides fragilis and their role in hexose and N-acetylglucosamine utilization. J. Bacteriol. 187:890-901.
32. Brioukhanov, A. L., and A. I. Netrusov. 2004. Catalase and superoxide dismutase: distribution, properties, and physiological role in cells of strict anaerobes. Biochemistry (Moscow) 69:949-962.
33. Britz, M. L., and R. G. Wilkinson. 1978. Chloramphenicol acetyl-transferase of Bacteroides fragilis. Antimicrob. Agents Chemother. 14:105-111.
34. Bron, P. A., M. Marco, S. M. Hoffer, M. E. Van, W. M. de Vos, and M. Kleerebezem. 2004. Genetic characterization of the bile salt response in Lactobacillus plantarum and analysis of responsive promoters in vitro and in situ in the gastrointestinal tract. J. Bacteriol. 186:7829-7835.
35. Brook, I. 2002. Anaerobic infections in children. Microbes. Infect. 4:1271-1280.
36. Brook, I. 2002. Joint and bone infections due to anaerobic bacteria in children. Pediatr. Rehabil. 5:11-19.
37. Brook, I. 2002. Microbiology and management of post-surgical wounds infection in children. Pediatr. Rehabil. 5:171-176.
38. Brook, I. 2003. Microbiology and management of intra-abdominal infections in children. Pediatr. Int. 45:123-129.
39. Brook, I. 2004. Intra-abdominal, retroperitoneal, and visceral abscesses in children. Eur. J. Pediatr. Surg. 14:265-273.
40. Brook, I. 2002. Pericarditis due to anaerobic bacteria. Cardiology 97:55-58.
41. Brook, I. 2002. Microbiology of polymicrobial abscesses and implications for therapy. J. Antimicrob. Chemother. 50:805-810.
42. Brook, I. 2002. Endocarditis due to anaerobic bacteria. Cardiology 98:1-5.
43. Reference deleted.
44. Brook, I. 2002. Clinical review: bacteremia caused by anaerobic bacteria in children. Crit. Care 6:205-211.
45. Brook, I. 1989. Aerobic and anaerobic microbiology of Bartholin's abscess. Surg. Gynecol. Obstet. 169:32-34.
46. Brook, I. 1986. Anaerobic osteomyelitis in children. Pediatr. Infect. Dis. 5:550-556.
47. Brook, I. 1990. Bacteremia due to anaerobic bacteria in newborns. J. Perinatol. 10:351-356.
48. Brook, I., J. C. Coolbaugh, and R. I. Walker. 1984. Pathogenicity of piliated and encapsulated Bacteroides fragilis. Eur. J. Clin. Microbiol. 3:207-209.
49. Brook, I., and E. H. Frazier. 1992. Microbiology of scalp abscess in newborns. Pediatr. Infect. Dis. J. 11:766-768.
50. Brook, I., N. Johnson, G. D. Overturf, and J. Wilkins. 1977. Mixed bacterial meningitis: a complication of ventriculo- and lumboperitoneal shunts. J. Neurosurg. 47:961-964.
51. Brook, I., and M. L. Myhal. 1991. Adherence of Bacteroides fragilis group species. Infect. Immun. 59:742-744.
52. Bryan, L. E., S. K. Kowand, and H. M. Van Den Elzen. 1979. Mechanism of aminoglycoside antibiotic resistance in anaerobic bacteria: Clostridium perfringens and Bacteroides fragilis. Antimicrob. Agents Chemother. 15:7-13.
53. Cash, H. L., C. V. Whitham, C. L. Behrendt, and L. V. Hooper. 2006. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313:1126-1130.
54. Cerdeno-Tarraga, A. M., S. Patrick, L. C. Crossman, G. Blakely, V. Abratt, N. Lennard, I. Poxton, B. Duerden, B. Harris, M. A. Quail, A. Barron, L. Clark, C. Corton, J. Doggett, M. T. Holden, N. Larke, A. Line, A. Lord, H. Norbertczak, D. Ormond, C. Price, E. Rabbinowitsch, J. Woodward, B. Barrell, and J. Parkhill. 2005. Extensive DNA inversions in the B. fragilis genome control variable gene expression. Science 307:1463-1465.
55. Reference deleted.
56. Chaudhry, R., P. Mathur, B. Dhawan, and L. Kumar. 2001. Emergence of metronidazole-resistant Bacteroides fragilis, India. Emerg. Infect. Dis. 7:485-486. (Letter.)
57. Chen, Y., T. Kinouchi, K. Kataoka, S. Akimoto, and Y. Ohnishi. 1995. Purification and characterization of a fibrinogen-degrading protease in Bacteroides fragilis strain YCH46. Microbiol. Immunol. 39:967-977.
58. Cho, K. H., D. Cho, G. R. Wang, and A. A. Salyers. 2001. New regulatory gene that contributes to control of Bacteroides thetaiotaomicron starch utilization genes. J. Bacteriol. 183:7198-7205.
59. Cho, K. H., and A. A. Salyers. 2001. Biochemical analysis of interactions between outer membrane proteins that contribute to starch utilization by Bacteroides thetaiotaomicron. J. Bacteriol. 183:7224-7230.
60. Cisneros, J. M., J. Rodriguez-Bano, F. Fernandez-Cuenca, A. Ribera, J. Vila, A. Pascual, L. Martinez-Martinez, G. Bou, and J. Pachon. 2005. Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study. Clin. Microbiol. Infect. 11:874-879.
61. Claros, M. C., Z. C. Claras, D. W. Hecht, D. M. Citron, E. J. Goldstein, J. Silva, Jr., Y. Tang-Feldman, and A. C. Rodloff. 2006. Characterization of the Bacteroides fragilis pathogenicity island in human blood culture isolates. Anaerobe 12:17-22.
62. Claros, M. C., Z. C. Claros, Y. J. Tang, S. H. Cohen, J. Silva, Jr., E. J. Goldstein, and A. C. Rodloff. 2000. Occurrence of Bacteroides fragilis enterotoxin gene-carrying strains in Germany and the United States. J. Clin. Microbiol. 38:1996-1997.
63. Clinical and Laboratory Standards Institute. 2006. Methods for antimicrobial susceptibility testing of anaerobic bacteria: approved standard, 7th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
64. Cohavy, O., D. Bruckner, L. K. Gordon, R. Misra, B. Wei, M. E. Eggena, S. R. Targan, and J. Braun. 2000. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infect. Immun. 68:1542-1548.
65. Comstock, L. E., and M. J. Coyne. 2003. Bacteroides thetaiotaomicron: a dynamic, niche-adapted human symbiont. Bioessays 25:926-929.
66. Corzo, G., and S. E. Gilliland. 1999. Measurement of bile salt hydrolase activity from Lactobacillus acidophilus based on disappearance of conjugated bile salts. J. Dairy Sci. 82:466-471.
67. Coyne, M. J., W. Kalka-Moll, A. O. Tzianabos, D. L. Kasper, and L. E. Comstock. 2000. Bacteroides fragilis NCTC9343 produces at least three distinct capsular polysaccharides: cloning, characterization, and reassignment of polysaccharide B and C biosynthesis loci. Infect. Immun. 68:6176-6181.
68. Coyne, M. J., B. Reinap, M. M. Lee, and L. E. Comstock. 2005. Human symbionts use a host-like pathway for surface fucosylation. Science 307:1778-1781.
69. Coyne, M. J., K. G. Weinacht, C. M. Krinos, and L. E. Comstock. 2003. Mpi recombinase globally modulates the surface architecture of a human commensal bacterium. Proc. Natl. Acad. Sci. USA 100:10446-10451.
70. De Boever, P., and W. Verstraete. 1999. Bile salt deconjugation by Lactobacillus plantarum 80 and its implication for bacterial toxicity. J. Appl. Microbiol. 87:345-352.
71. Delahooke, D. M., G. R. Barclay, and I. R. Poxton. 1995. A re-appraisal of the biological activity of bacteroides [sic] LPS. J. Med. Microbiol. 42:102-112.
72. D'Elia, J. N., and A. A. Salyers. 1996. Contribution of a ncopullulanase, a pullulanase, and an alpha-glucosidase to growth of Bacteroides thetaiotaomicron on starch. J. Bacteriol. 178:7173-7179.
73. D'Elia, J. N., and A. A. Salyers. 1996. Effect of regulatory protein levels on utilization of starch by Bacteroides thetaiotaomicron. J. Bacteriol. 178:7180-7186.
74. de O. Ferreira, E., L. Araujo Lobo, D. Barreiros Petropolis, K. dos S. Avelar, M. C. Ferreira, F. Costa e Silva Filho, and R. M. Domingues. 2006. A Bacteroides fragilis surface glycoprotein mediates the interaction between the bacterium and the extracellular matrix component laminin-1. Res. Microbiol. 157:960-966.
75. Diniz, C. G., L. M. Farias, M. A. Carvalho, E. R. Rocha, and C. J. Smith. 2004. Differential gene expression in a Bacteroides fragilis metronidazole-resistant mutant. J. Antimicrob. Chemother. 54:100-108.
76. Dodd, M. J., I. D. Griffiths, and R. Freeman. 1982. Pyogenic arthritis due to bacteroides [sic] complicating rheumatoid arthritis. Ann. Rheum. Dis. 41:248-249.
77. Domingues, R. M., S. M. Cavalcanti, A. F. Andrade, and M. C. Ferreira. 1992. Sialic acid as receptor of Bacteroides fragilis lectin-like adhesin. Zentbl. Bakteriol. 277:340-344.
78. Domingues, R. M., W. das G. Silva e Souza, S. R. Moraes, K. E. Avelar, J. R. Hirata, M. E. Fonseca, and M. C. Ferreira. 1997. Surface vesicles: a possible function in commensal relations of Bacteroides fragilis. Zentbl. Bakteriol. 285:509-517.
79. Duncan, S. H., A. Belenguer, G. Holtrop, A. M. Johnstone, H. J. Flint, and G. E. Lobley. 2007. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyratc and butyrate-producing bacteria in feces. Appl. Environ. Microbiol. 73:1073-1078.
80. Dutson, T. R., A. M. Pearson, J. F. Price, G. C. Spink, and P. J. Tarrant. 1971. Observations by electron microscopy on pig muscle inoculated and incubated with Pseudomonas fragi. Appl. Microbiol. 22:1152-1158.
81. Edmiston, C. E., Jr., C. J. Krepel, K. S. Kehl, G. R. Seabrook, L. B. Somberg, G. H. Almassi, T. L. Smith, T. A. Loehrl, K. R. Brown, B. D. Lewis, and J. B. Towne. 2005. Comparative in vitro antimicrobial activity of a novel quinolonc, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients. J. Antimicrob. Chemother. 56:872-878.
82. Edwards, R. 1997. Resistance to beta-lactam antibiotics in Bacteroides spp. J. Med. Microbiol. 46:979-986.
83. Edwards, R., and D. Greenwood. 1996. Mechanisms responsible for reduced susceptibility to imipenem in Bacteroides fragilis. J. Antimicrob. Chemother. 38:941-951.
84. Elliott, D., J. A. Kufera, and R. A. Myers. 2000. The microbiology of necrotizing soft tissue infections. Am. J. Surg. 179:361-366.
85. Fang, H., C. Edlund, C. E. Nord, and M. Hedberg. 2002. Selection of ccfoxitin-resistant Bacteroides thetaiotaomicron mutants and mechanisms involved in β-lactam resistance. Clin. Infect. Dis. 35:S47-S53.
86. Fenner, L., V. Roux, M. N. Mallet, and D. Raoult. 2005. Bacteroides massiliensis sp. nov., isolated from blood culture of a newborn. Int. J. Syst. Evol. Microbiol. 55:1335-1337.
87. Ferreira, R., M. C. Alexandre, E. N. Antunes, A. T. Pinhao, S. R. Moraes, M. C. Ferreira, and R. M. Domingues. 1999. Expression of Bacteroides fragilis virulence markers in vitro. J. Med. Microbiol. 48:999-1004.
88. Feuillet, L., J. Carvajal, I. Sudre, J. Pelletier, J. M. Thomassin, M. Drancourt, and A. A. Cherif. 2005. First isolation of Bacteroides thetaiotaomicron from a patient with a cholesteatoma and experiencing meningitis. J. Clin. Microbiol. 43:1467-1469.
89. Fletcher, H. M., and F. L. Macrina. 1991. Molecular survey of clindamycin and tetracycline resistance determinants in Bacteroides species. Antimicrob. Agents Chemother. 35:2415-2418.
90. Forum on Microbial Threats. 2006. Manipulating host-microbe interactions: probiotic research and regulations, p. 207. In Ending the war metaphor: the changing agenda for unraveling the host-microbe relationship. The National Academies Press, Washington, DC.
91. Franco, A. A. 2004. The Bacteroides fragilis pathogenicity island is contained in a putative novel conjugative transposon. J. Bacteriol. 186:6077-6092.
92. Franco, A. A., R. K. Cheng, G. T. Chung, S. Wu, H. B. Oh, and C. L. Sears. 1999. Molecular evolution of the pathogenicity island of enterotoxigenic Bacteroides fragilis strains. J. Bacteriol. 181:6623-6633.
93. Frank, G. R., and L. G. Rubin. 1989. Mixed meningitis with Bacteroides ovatus caused by an occult congenital dermal sinus. Pediatr. Infect. Dis. J. 8:401-403.
94. Freitas, M., E. Tavan, C. Cayuela, L. Diop, C. Sapin, and G. Trugnan. 2003. Host-pathogens cross-talk, indigenous bacteria and probiotics also play the game. Biol. Cell 95:503-506.
95. Fujita, H., Y. Eishi, I. Ishige, K. Saitoh, T. Takizawa, T. Arima, and M. Koike. 2002. Quantitative analysis of bacterial DNA from Mycobacteria spp., Bacteroides vulgatus, and Escherichia coli in tissue samples from patients with inflammatory bowel diseases. J. Gastroenterol. 37:509-516.
96. Gal, M., and J. S. Brazier. 2004. Metronidazole resistance in Bacteroides spp. carrying nim genes and the selection of slow-growing metronidazole-rcsistant mutants. J. Antimicrob. Chemother. 54:109-116.
97. Ganz, T. 2000. Paneth cells-guardians of the gut cell hatchery. Nat. Immunol. 1:99-100.
98. Gemmell, C. G., P. K. Peterson, D. Schmeling, J. Mathews, and P. G. Quie. 1983. Antibiotic-induced modification of Bacteroides fragilis and its susceptibility to phagocytosis by human polymorphonuclear leukocytes. Eur. J. Clin. Microbiol. 2:327-334.
99. Georgopapadakou, N. H., S. A. Smith, and R. B. Sykes. 1983. Penicillin-binding proteins in Bacteroides fragilis. J. Antibiot. (Tokyo) 36:907-910.
100. Germain, M., M. A. Krohn, S. L. Hillier, and D. A. Eschenbach. 1994. Genital flora in pregnancy and its association with intrauterine growth retardation. J. Clin. Microbiol. 32:2162-2168.
101. Gibson, S. A., and G. T. Macfarlane. 1988. Characterization of proteases formed by Bacteroides fragilis. J. Gen. Microbiol. 134:2231-2240.
102. Gill, S. R., M. Pop, R. T. DeBoy, P. B. Eckburg, P. J. Turnbaugh, B. S. Samuel, J. I. Gordon, D. A. Relman, C. M. Fraser-Liggett, and K. E. Nelson. 2006. Metagenomic analysis of the human distal gut microbiome. Science 312:1355-1359.
103. Gillespie, W. A., and J. Guy. 1956. Bacteroides in intra-abdominal sepsis. Lancet i:1039-1041.
104. Gilmore, M. S., and J. J. Ferretti. 2003. The thin line between gut commensal and pathogen. Science 299:1999-2002.
105. Godoy, V. G., M. M. Dallas, T. A. Russo, and M. H. Malamy. 1993. A role for Bacteroides fragilis neuraminidase in bacterial growth in two model systems. Infect. Immun. 61:4415-4426.
106. Goh, B. K., G. Alkouder, T. K. Lama, and C. E. Tan. 2005. Multi-drug-resistant Acinetobacter baumannii intra-abdominal abscess. Surg. Infect. 6:345-347.
107. Goldstein, E. J. 1996. Anaerobic bacteremia. Clin. Infect. Dis. 23(Suppl. 1):S97-S101.
108. Gootz, T. D. 2006. The forgotten Gram-negative bacilli: what genetic determinants are telling us about the spread of antibiotic resistance. Biochem. Pharmacol. 71:1073-1084.
109. Grenier, D., and D. Mayrand. 1987. Functional characterization of extracellular vesicles produced by Bacteroides gingivalis. Infect. Immun. 55:111-117.
110. Guzman, C. A., M. Plate, and C. Pruzzo. 1990. Role of neuraminidase-depcndent adherence in Bacteroides fragilis attachment to human epithelial cells. FEMS Microbiol. Lett. 59:187-192.
111. Haggoud, A., G. Reysset, H. Azeddoug, and M. Sebald. 1994. Nucleotide sequence analysis of two 5-nitroimidazolc resistance determinants from Bacteroides strains and of a new insertion sequence upstream of the two genes. Antimicrob. Agents Chemother. 38:1047-1051.
112. Hart, C. A., V. M. Godfrey, J. C. Woodrow, and A. Percival. 1982. Septic arthritis due to Bacteroides fragilis in a wrist affected by rheumatoid arthritis. Ann. Rheum. Dis. 41:623-624.
113. Hecht, D. W. 2006. Anaerobes: antibiotic resistance, clinical significance, and the role of susceptibility testing. Anaerobe 12:115-121.
114. Hecht, D. W. 2004. Prevalence of antibiotic resistance in anaerobic bacteria: worrisome developments. Clin. Infect. Dis. 39:92-97.
115. Hedberg, M., and C. E. Nord. 2003. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe. Clin. Microbiol. Infect. 9:475-488.
116. Heinonen, P. K., and M. Leinonen. 2003. Fecundity and morbidity following acute pelvic inflammatory disease treated with doxycycline and metronidazole. Arch. Gynecol. Obstet. 268:284-288.
117. Hooper, L. V., and J. I. Gordon. 2001. Commensal host-bacterial relationships in the gut. Science 292:1115-1118.
118. Hooper, L. V., T. Midtvedt, and J. I. Gordon. 2002. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 22:283-307.
119. Hooper, L. V., T. S. Stappenbeck, C. V. Hong, and J. I. Gordon. 2003. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat. Immunol. 4:269-273.
120. Hooper, L. V., M. H. Wong, A. Thelin, L. Hansson, P. G. Falk, and J. I. Gordon. 2001. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291:881-884.
121. Hooper, L. V., J. Xu, P. G. Falk, T. Midtvedt, and J. I. Gordon. 1999. A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc. Natl. Acad. Sci. USA 96:9833-9838.
122. Hopkins, M. J., and G. T. Macfarlane. 2002. Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J. Med. Microbiol. 51:448-454.
123. Hopkins, M. J., and G. T. Macfarlane. 2003. Nondigcstiblc oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro. Appl. Environ. Microbiol. 69:1920-1927.
124. Hung, M. N., S. Y. Chen, J. L. Wang, S. C. Chang, P. R. Hsueh, C. H. Liao, and Y. C. Chen. 2005. Community-acquired anaerobic bacteremia in adults: one-year experience in a medical center. J. Microbiol. Immunol. Infect. 38:436-443.
125. Jain, R., and L. H. Danziger. 2004. Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians. Ann. Pharmacother. 38:1449-1459.
126. Johnson, C. C., J. F. Reinhardt, M. A. Edelstein, M. E. Mulligan, W. L. George, and S. M. Finegold. 1985. Bacteroides gracilis, an important anaerobic bacterial pathogen. J. Clin. Microbiol. 22:799-802.
127. Jousimies-Somer, H., P. Summanen, D. M. Citron, E. J. Baron, H. M. Wexler, and S. M. Finegold. 2002. Wadsworth-KTL anaerobic bacteriology manual. Star Publishing Company, Belmont, CA.
128. Jousimies-Somer, H., P. Summanen, and S. M. Finegold. 2003. Bacteroides, Porphyromonas, Prevotella, Fusobacterium and other anaerobic gram-negative rods and cocci, p. 690-711. In P. R. Murray, E. J. Baron, J. H. P. M. A. Jorgensen, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed. ASM Press, Washington, DC.
129. Kalka-Moll, W. M., Y. Wang, L. E. Comstock, S. E. Gonzalez, A. O. Tzianabos, and D. L. Kasper. 2001. Immunochemical and biological characterization of three capsular polysaccharides from a single Bacteroides fragilis strain. Infect. Immun. 69:2339-2344.
130. Kanazawa, K., Y. Kobayashi, H. Nakano, M. Sakurai, N. Gotoh, and T. Nishino. 1995. Identification of three porins in the outer membrane of Bacteroides fragilis. FEMS Microbiol. Lett. 127:181-186.
131. Kazmierczak, M. J., M. Wiedmann, and K. J. Boor. 2005. Alternative sigma factors and their roles in bacterial virulence. Microbiol. Mol. Biol. Rev. 69:527-543.
132. Khandelwal, P., D. Choudhury, A. Birah, M. K. Reddy, G. P. Gupta, and N. Banerjee. 2004. Insecticidal pilin subunit from the insect pathogen Xenorhabdus nematophila. J. Bacteriol. 186:6465-6476.
133. Kim, J. M., J. Y. Lee, Y. M. Yoon, Y. K. Oh, J. S. Kang, Y. J. Kim, and K. H. Kim. 2006. Bacteroides fragilis enterotoxin induces cyclooxygenase-2 and fluid secretion in intestinal epithelial cells through NF-kappaB activation. Eur. J. Immunol. 36:2446-2456.
134. Kislak, J. W. 1972. The susceptibility of Bacteroides fragilis to 24 antibiotics. J. Infect. Dis. 125:295-298.
135. Kitahara, M., M. Sakamoto, M. Ike, S. Sakata, and Y. Benno. 2005. Bacteroides plebeius sp. nov. and Bacteroides coprocola sp. nov., isolated from human faeces. Int. J. Syst. Evol. Microbiol. 55:2143-2147.
136. Kling, J. J., R. L. Wright, J. S. Moncrief, and T. D. Wilkins. 1997. Cloning and characterization of the gene for the metalloprotease enterotoxin of Bacteroides fragilis. FEMS Microbiol. Lett. 146:279-284.
137. Krinos, C. M., M. J. Coyne, K. G. Weinacht, A. O. Tzianabos, D. L. Kasper, and L. E. Comstock. 2001. Extensive surface diversity of a commensal microorganism by multiple DNA inversions. Nature 414:555-558.
138. Kuwahara, T., A. Yamashita, H. Hirakawa, H. Nakayama, H. Toh, N. Okada, S. Kuhara, M. Hattori, T. Hayashi, and Y. Ohnishi. 2004. Genomic analysis of Bacteroides fragilis reveals extensive DNA inversions regulating cell surface adaptation. Proc. Natl. Acad. Sci. USA 101:14919-14924.
139. Lassmann, B., D. R. Gustafson, C. M. Wood, and J. E. Rosenblatt. 2007. Reemergence of anaerobic bacteremia. Clin. Infect. Dis. 44:895-900.
140. Leng, Z., D. E. Riley, R. E. Berger, J. N. Krieger, and M. C. Roberts. 1997. Distribution and mobility of the tetracycline resistance determinant tetQ. J. Antimicrob. Chemother. 40:551-559.
141. Leszczynski, P., F. Meisel-Mikolajczyk, M. Dworczynska, L. Cwyl-Zembrzuska, and L. Marianowski. 1995. Occurrence of Bacteroides fragilis strains in full term and post term pregnancies. Ginekol. Pol. 66:324-329.
142. Leszczynski, P., B. A. Van, H. Pituch, H. Verbrugh, and F. Meisel-Mikolajczyk. 1997. Vaginal carriage of enterotoxigenic Bacteroides fragilis in pregnant women. J. Clin. Microbiol. 35:2899-2903.
143. Ley, R. E., F. Backhed, P. Turnbaugh, C. A. Lozupone, R. D. Knight, and J. I. Gordon. 2005. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 102:11070-11075.
144. Ley, R. E., P. J. Turnbaugh, S. Klein, and J. I. Gordon. 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444:1022-1023.
145. Lindner, J. G., F. H. Plantema, and J. A. Hoogkamp-Korstanje. 1978. Quantitative studies of the vaginal flora of healthy women and of obstetric and gynaecological patients. J. Med. Microbiol. 11:233-241.
146. Liu, C., Y. Song, M. McTeague, A. W. Vu, H. Wexler, and S. M. Finegold. 2003. Rapid identification of the species of the Bacteroides fragilis group by multiplex PCR assays using group- and species-specific primers. FEMS Microbiol. Lett. 222:9-16.
147. Livermore, D. M., and N. Woodford. 2000. Carbapenemases: a problem in waiting? Curr. Opin. Microbiol. 3:489-495.
148. Lofmark, S., H. Fang, M. Hedberg, and C. Edlund. 2005. Inducible metronidazole resistance and nim genes in clinical Bacteroides fragilis group isolates. Antimicrob. Agents Chemother. 49:1253-1256.
149. Macfarlane, G. T., S. Macfarlane, and G. R. Gibson. 1992. Synthesis and release of proteases by Bacteroides fragilis. Curr. Microbiol. 24:55-59.
150. Mackie, R. I., A. Sghir, and H. R. Gaskins. 1999. Developmental microbial ecology of the neonatal gastrointestinal tract. Am. J. Clin. Nutr. 69:1035S-1045S.
151. Marculescu, C. E., E. F. Berbari, F. R. Cockerill III, and D. R. Osmon. 2006. Unusual aerobic and anaerobic bacteria associated with prosthetic joint infections. Clin. Orthop. Relat. Res. 451:55-63.
152. Martinez-Suarez, J. V., F. Baquero, M. Reig, and J. C. Perez-Diaz. 1985. Transferable plasmid-linkcd chloramphenicol acetyltransferase conferring high-level resistance in Bacteroides uniformis. Antimicrob. Agents Chemother. 28:113-117.
153. Mashburn, L. M., and M. Whiteley. 2005. Membrane vesicles traffic signals and facilitate group activities in a prokaryote. Nature 437:422-425.
154. Mazmanian, S. K., and D. L. Kasper. 2006. The love-hate relationship between bacterial polysaccharides and the host immune system. Nat. Rev. Immunol. 6:849-858.
155. Mazmanian, S. K., C. H. Liu, A. O. Tzianabos, and D. L. Kasper. 2005. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122:107-118. (Comment.).
156. McCarthy, R. E., M. Pajeau, and A. A. Salyers. 1988. Role of starch as a substrate for Bacteroides vulgatus growing in the human colon. Appl. Environ. Microbiol. 54:1911-1916.
157. Merle-Melet, M., D. Mainard, D. Regent, C. Dopff, J. N. Tamisier, P. Ross, J. P. Delagoutte, and A. Gerard. 1994. An unusual case of hip septic arthritis due to Bacteroides fragilis in an alcoholic patient. Infection 22:353-355.
158. Merriam, C. V., H. T. Fernandez, D. M. Citron, K. L. Tyrrell, Y. A. Warren, and E. J. Goldstein. 2003. Bacteriology of human bite wound infections. Anaerobe 9:83-86.
159. Miki, T., T. Kuwahara, H. Nakayama, N. Okada, K. Kataoka, H. Arimochi, and Y. Ohnishi. 2005. Simultaneous detection of Bacteroides fragilis group species by leuB-directed PCR. J. Med. Investig. 52:101-108.
160. Miyamae, S., H. Nikaido, Y. Tanaka, and F. Yoshimura. 1998. Active efflux of norfloxacin by Bacteroides fragilis. Antimicrob. Agents Chemother. 42:2119-2121.
161. Miyamae, S., O. Ueda, F. Yoshimura, J. Hwang, Y. Tanaka, and H. Nikaido. 2001. A MATE family multidrug efflux transporter pumps out fluoroquinolones in Bacteroides thetaiotaomicron. Antimicrob. Agents Chemother. 45:3341-3346.
162. Moncrief, J. S., R. Obiso, Jr., L. A. Barroso, J. J. Kling, R. L. Wright, R. L. Van Tassell, D. M. Lyerly, and T. D. Wilkins. 1995. The enterotoxin of Bacteroides fragilis is a metalloprotease. Infect. Immun. 63:175-181.
163. Montejo, B. M., A. P. Gonzalez de Zarate, F. J. Barron, and E. C. Aguirre. 1984. Meningitis caused by Bacteroides fragilis. Can. Med. Assoc. J. 131: 184-186.
164. Moon, K., N. B. Shoemaker, J. F. Gardner, and A. A. Salyers. 2005. Regulation of excision genes of the Bacteroides conjugative transposon CTnDOT. J. Bacteriol. 187:5732-5741.
165. Mossie, K. G., F. T. Robb, D. T. Jones, and D. R. Woods. 1981. Inhibition of ribonucleic acid polymerase by a bacteriocin from Bacteroides fragilis. Antimicrob. Agents Chemother. 20:437-442.
166. Nakano, V., G. Padilla, M. M. do Valle, and M. J. Vila-Campos. 2004. Plasmid-related beta-lactamase production in Bacteroides fragilis strains. Res. Microbiol. 155:843-846.
167. Namavar, F., M. W. Van der Bijl, B. J. Appelmelk, J. de Graaff, and D. M. Maclaren. 1994. The role of neuraminidase in haemagglutination and adherence to colon WiDr cells by Bacteroides fragilis. J. Med. Microbiol. 40:393-396.
168. Ngan, C. C., and A. L. Tan. 1994. Bacteroides fragilis meningitis. Singapore Med. J. 35:283-285.
169. Nguyen, M. H., V. L. Yu, A. J. Morris, L. McDermott, M. W. Wagener, L. Harrell, and D. R. Snydman. 2000. Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. Clin. Infect. Dis. 30:870-876.
170. Odou, M. F., E. Singer, and L. Dubreuil. 2001. Description of complex forms of a porin in Bacteroides fragilis and possible implication of this protein in antibiotic resistance. Anaerobe 7:219-225.
171. Odou, M. F., E. Singer, M. B. Romond, and L. Dubreuil. 1998. Isolation and characterization of a porin-like protein of 45 kilodaltons from Bacteroides fragilis. FEMS Microbiol. Lett. 166:347-354.
172. Odugbemi, T., S. A. Jatto, and K. Afolabi. 1985. Bacteroides fragilis meningitis. J. Clin. Microbiol. 21:282-283.
173. Ogawa, W., D. W. Li, P. Yu, A. Begum, T. Mizushima, T. Kuroda, and T. Tsuchiya. 2005. Multidrug resistance in Klebsiella pneumoniae MGH78578 and cloning of genes responsible for the resistance. Biol. Pharm. Bull. 28:1505-1508.
174. Oh, H., N. El Amin, T. Davies, P. C. Appelbaum, and C. Edlund. 2001. gyrA mutations associated with quinolone resistance in Bacteroides fragilis group strains. Antimicrob. Agents Chemother. 45:1977-1981.
175. Osborne, N. G. 2006. The role of Bacteroides fragilis in pelvic infections. J. Gynecol. Surg. 22:81-82.
176. Otto, B. R., M. Sparrius, A. M. Verweij-van Vught, and D. M. Maclaren. 1990. Iron-regulated outer membrane protein of Bacteroides fragilis involved in heme uptake. Infect. Immun. 58:3954-3958.
177. Oyston, P. C., and P. S. Handley. 1990. Surface structures, haemagglutination and cell surface hydrophobicity of Bacteroides fragilis strains. J. Gen. Microbiol. 136:941-948.
178. Oyston, P. C., and P. S. Handley. 1991. Surface components of Bacteroides fragilis involved in adhesion and haemagglutination. J. Med. Microbiol. 34:51-55.
179. Pantosti, A., A. O. Tzianabos, A. B. Onderdonk, and D. L. Kasper. 1991. Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis. Infect. Immun. 59:2075-2082.
180. Pantosti, A., A. O. Tzianabos, B. G. Reinap, A. B. Onderdonk, and D. L. Kasper. 1993. Bacteroides fragilis strains express multiple capsular polysaccharides. J. Clin. Microbiol. 31:1850-1855.
181. Park, J. T. 2001. Identification of a dedicated recycling pathway for anhydro-N-acetylmuramic acid and N-acetylglucosamine derived from Escherichia coli cell wall murein. J. Bacteriol. 183:3842-3847.
182. Parker, A. C., and C. J. Smith. 1993. Genetic and biochemical analysis of a novel Ambler class A beta-lactamase responsible for cefoxitin resistance in Bacteroides species. Antimicrob. Agents Chemother. 37:1028-1036.
183. Patey, O., J. Breuil, A. Fisch, C. Burnat, F. Vincent-Ballereau, and A. Dublanchet. 1990. Bacteroides fragilis meningitis: report of two cases. Rev. Infect. Dis. 12:364-365.
184. Patrick, S., D. Gilpin, and L. Stevenson. 1999. Detection of intrastrain antigenic variation of Bacteroides fragilis surface polysaccharides by monoclonal antibody labelling. Infect. Immun. 67:4346-4351.
185. Patrick, S., J. P. McKenna, S. O'Hagan, and E. Dermott. 1996. A comparison of the haemagglutinating and enzymic activities of Bacteroides fragilis whole cells and outer membrane vesicles. Microb. Pathog. 20:191-202.
186. Paulsen, I. T., L. Banerjei, G. S. Myers, K. E. Nelson, R. Seshadri, T. D. Read, D. E. Fouts, J. A. Eisen, S. R. Gill, J. F. Heidelberg, H. Tettelin, R. J. Dodson, L. Umayam, L. Brinkac, M. Beanan, S. Daugherty, R. T. DeBoy, S. Durkin, J. Kolonay, R. Madupu, W. Nelson, J. Vamathevan, B. Tran, J. Upton, T. Hansen, J. Shetty, H. Khouri, T. Utterback, D. Radune, K. A. Ketchum, B. A. Dougherty, and C. M. Fraser. 2003. Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis. Science 299: 2071-2074.
187. Piddock, L. J. V., and R. Wise. 1987. Cefoxitin resistance in Bacteroides species: evidence indicating two mechanisms causing decreased susceptibility. J. Antimicrob. Chemother. 19:161-170.
188. Piriz, S., S. Vadillo, A. Quesada, J. Criado, R. Cerrato, and J. Ayala. 2004. Relationship between penicillin-binding protein patterns and beta-lactamases in clinical isolates of Bacteroides fragilis with different susceptibility to beta-lactam antibiotics. J. Med. Microbiol. 53:213-221.
189. Podglajen, I., J. Breuil, and E. Collatz. 1994. Insertion of a novel DNA sequence, IS1186, upstream of the silent carbapenemase gene cfiA, promotes expression of carbapenem resistance in clinical isolates of Bacteroides fragilis. Mol. Microbiol. 12:105-114.
190. Polk, B. F., and D. L. Kasper. 1977. Bacteroides fragilis subspecies in clinical isolates. Ann. Intern. Med. 86:569-571.
191. Poole, K., and R. Srikumar. 2001. Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance. Curr. Top. Med. Chem. 1:59-71.
192. Prindiville, T. P., R. A. Sheikh, S. H. Cohen, Y. J. Tang, M. C. Cantrell, and J. Silva, Jr. 2000. Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. Emerg. Infect. Dis. 6:171-174.
193. Pruzzo, C., B. Dainelli, and M. Ricchetti. 1984. Piliated Bacteroides fragilis strains adhere to epithelial cells and are more sensitive to phagocytosis by human neutrophils than nonpiliated strains. Infect. Immun. 43:189-194.
194. Pumbwe, L., A. Chang, R. L. Smith, and H. M. Wexler. 2006. Clinical significance of overexpression of multiple RND-family efflux pumps in Bacteroides fragilis isolates. J. Antimicrob. Chemother. 58:543-548.
195. Pumbwe, L., A. Chang, and H. M. Wexler. 2007. The RND-family transport system BmeRABC-5 is a metronidazole efflux pump in Bacteroides fragilis. Microb. Drug Resist. 13:96-101.
196. Pumbwe, L., D. Glass, and H. M. Wexler. 2006. Efflux pump overexpression in multiple antibiotic resistant mutants of Bacteroides fragilis. Antimicrob. Agents Chemother. 50:3150-3153.
197. Pumbwe, L., C. Skilbeck, A. Oren, and H. M. Wexler. 2007. Bile salts enhance bacterial co-aggregation, bacterial-intestinal epithelial cell adhesion, biofilm formation and antimicrobial resistance of Bacteroides fragilis. Microb. Pathog. 43:78-87.
198. Pumbwe, L., C. Skilbeck, and H. M. Wexler. Impact of anatomic site on growth, efflux pump expression, cell structure and stress responsiveness of Bacteroides fragilis. Curr. Microbiol., in press.
199. Pumbwe, L., C. A. Skilbeck, and H. M. Wexler. 2006. The Bacteroides fragilis cell envelope: quarterback, linebacker, coach - or all three? Anaerobe 12:211-220.
200. Pumbwe, L., O. Ueda, F. Yoshimura, A. Chang, R. Smith, and H. M. Wexler. 2006. Bacteroides fragilis BmeABC efflux systems additively confer intrinsic antimicrobial resistance. J. Antimicrob. Chemother. 58:37-46.
201. Pumbwe, L., D. W. Wareham, J. Aduse-Opoku, J. S. Brazier, and H. M. Wexler. 2007. Genetic analysis of mechanisms of multidrug resistance in a clinical isolate of Bacteroides fragilis. Clin. Microbiol. Infect. 13:183-189.
202. Ramsay, A. G., K. P. Scott, J. C. Martin, M. T. Rincon, and H. J. Flint. 2006. Cell-associated alpha-amylases of butyrate-producing Firmicute bacteria from the human colon. Microbiology 152:3281-3290.
203. Rasmussen, B. A., K. Bush, and F. P. Tally. 1993. Antimicrobial resistance in Bacteroides. Clin. Infect. Dis. 16(Suppl. 4):S390-S400.
204. Rasmussen, B. A., and E. Kovacs. 1993. Cloning and identification of a two-component signal-transducing regulatory system from Bacteroides fragilis. Mol. Microbiol. 7:765-776.
205. Rasmussen, J. L., D. A. Odelson, and F. L. Macrina. 1987. Complete nucleotide sequence of insertion element IS4351 from Bacteroides fragilis. J. Bacteriol. 169:3573-3580.
206. Reeves, A. R., J. N. D'Elia, J. Frias, and A. A. Salyers. 1996. A Bacteroides thetaiotaomicron outer membrane protein that is essential for utilization of maltooligosaccharides and starch. J. Bacteriol. 178:823-830.
207. Reeves, A. R., G. R. Wang, and A. A. Salyers. 1997. Characterization of four outer membrane proteins that play a role in utilization of starch by Bacteroides thetaiotaomicron. J. Bacteriol. 179:643-649.
208. Reid, G. 2004. When microbe meets human. Clin. Infect. Dis. 39:827-830.
209. Reid, J. H., and S. Patrick. 1984. Phagocytic and serum killing of capsulate and non-capsulate Bacteroides fragilis. J. Med. Microbiol. 17:247-257.
210. Renz, H., N. Blumer, S. Virna, S. Sel, and H. Garn. 2006. The immunological basis of the hygiene hypothesis. Chem. Immunol. Allergy 91:30-48.
211. Reysset, G. 1996. Genetics of 5-nitroimidazole resistance in Bacteroides species. Anaerobe 2:59-69.
212. Rhee, K. J., P. Sethupathi, A. Driks, D. K. Lanning, and K. L. Knight. 2004. Role of commensal bacteria in development of gut-associated lymphoid tissues and preimmune antibody repertoire. J. Immunol. 172:1118-1124.
213. Ricci, V., M. L. Peterson, J. C. Rotschafer, H. Wexler, and L. J. Piddock. 2004. Role of topoisomerase mutations and efflux in fluoroquinolone resistance of Bacteroides fragilis clinical isolates and laboratory mutants. Antimicrob. Agents Chemother. 48:1344-1346.
214. Riepe, S. P., J. Goldstein, and D. H. Alpers. 1980. Effect of secreted Bacteroides proteases on human intestinal brush border hydrolases. J. Clin. Investig. 66:314-322.
215. Roberts, M. C. 2003. Acquired tetracycline and/or macrolide-lincosamides-streptogramin resistance in anaerobes. Anaerobe 9:63-69.
216. Robertson, K. P., C. J. Smith, A. M. Gough, and E. R. Rocha. 2006. Characterization of Bacteroides fragilis hemolysins and regulation and synergistic interactions of HlyA and HlyB. Infect. Immun. 74:2304-2316.
217. Rocha, E. R., T. Selby, J. P. Coleman, and C. J. Smith. 1996. Oxidative stress response in an anaerobe, Bacteroides fragilis: a role for catalase in protection against hydrogen peroxide. J. Bacteriol. 178:6895-6903.
218. Rogemond, V., and R. M. Guinet. 1986. Lectinlike adhesins in the Bacteroides fragilis group. Infect. Immun. 53:99-102.
219. Rogers, M. B., A. C. Parker, and C. J. Smith. 1993. Cloning and characterization of the endogenous cephalosporinase gene, cepA, from Bacteroides fragilis reveals a new subgroup of Ambler class A beta-lactamases. Antimicrob. Agents Chemother. 37:2391-2400.
220. Rosenkranz, P., M. M. Lederman, K. V. Gopalakrishna, and J. J. Ellner. 1990. Septic arthritis caused by Bacteroides fragilis. Rev. Infect. Dis. 12:20-30.
221. Rotimi, V. O., T. L. Verghese, N. Al-Sweih, F. B. Khodakhast, and K. Ahmed. 2000. Influence of five antianaerobic antibiotics on endotoxin liberation by gram-negative anaerobes. J. Chemother. 12:40-47.
222. Rudek, W., and R. U. Haque. 1976. Extracellular enzymes of the genus Bacteroides. J. Clin. Microbiol. 4:458-460.
223. Russo, T. A., J. S. Thompson, V. G. Godoy, and M. H. Malamy. 1990. Cloning and expression of the Bacteroides fragilis TAL2480 neuraminidase gene, nanH, in Escherichia coli. J. Bacteriol. 172:2594-2600.
224. Sachs, J. 2005. Are antibiotics killing us? Discover 26:36.
225. Sakamoto, M., and Y. Benno. 2006. Reclassification of Bacteroides distasonis, Bacteroides goldsteinii and Bacteroides merdae as Parabacteroides distasonis gen.nov, comb, nov., Parabacteroides goldsteinii comb. nov. and Parabacteroides merdae comb. nov. Int. J. Syst. Bacteriol. 56:1599-1605.
226. Salyers, A. A. 1984. Bacteroides of the human lower intestinal tract. Annu. Rev. Microbiol. 38:293-313.
227. Salyers, A. A., and C. F. Amabile-Cuevas. 1997. Why are antibiotic resistance genes so resistant to elimination? Antimicrob. Agents Chemother. 41:2321-2325.
228. Salyers, A. A., A. Gupta, and Y. Wang. 2004. Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol. 12:412-416.
229. Salyers, A. A., and M. Pajeau. 1989. Competitiveness of different polysaccharide utilization mutants of Bacteroides thetaiotaomicron in the intestinal tracts of germfree mice. Appl. Environ. Microbiol. 55:2572-2578.
230. Salyers, A. A., N. B. Shoemaker, and L. Y. Li. 1995. In the driver's scat: the Bacteroides conjugative transposons and the elements they mobilize. J. Bacteriol. 177:5727-5731.
231. Salyers, A. A., N. B. Shoemaker, A. M. Stevens, and L. Y. Li. 1995. Conjugative transposons: an unusual and diverse set of integrated gene transfer elements. Microbiol. Rev. 59:579-590.
232. Salyers, A. A., B. S. Speer, and N. B. Shoemaker. 1990. New perspectives in tetracycline resistance. Mol. Microbiol. 4:151-156.
233. Salyers, A. A., P. Valentine, and V. Hwa. 1993. Genetics of polysaccharide utilization pathways of colonic Bacteroides species, p. 505-516. In M. Sebald (ed.), Genetics and molecular biology of anaerobic bacteria. Springer-Verlag, New York, NY.
234. Sanchez, S. 2006. Where do antimicrobial resistances reside on the farm?, abstr. A-108. Abstr. 105th Gen. Meet. Am. Soc. Microbiol. American Society for Microbiology, Washington, DC.
235. San Joaquin, V., J. C. Griffis, C. Lee, and C. L. Sears. 1995. Association of Bacteroides fragilis with childhood diarrhea. Scand. J. Infect. Dis. 27:211-215.
236. Schapiro, J. M., R. Gupta, E. Stefansson, F. C. Fang, and A. P. Limaye. 2004. Isolation of metronidazole-resistant Bacteroides fragilis carrying the nimA nitroreductase gene from a patient in Washington State. J. Clin. Microbiol. 42:4127-4129.
237. Schauer, R. 2004. Sialic acids: fascinating sugars in higher animals and man. Zoology (Jena) 107:49-64.
238. Sears, C. L. 2001. The toxins of Bacteroides fragilis. Toxicon 39:1737-1746.
239. Senneville, E., C. Savage, I. Nallet, Y. Yazdanpanah, F. Giraud, H. Migaud, L. Dubreuil, R. Courcol, and Y. Mouton. 2006. Improved aero-anaerobe recovery from infected prosthetic joint samples taken from 72 patients and collected intraoperatively in Rosenow's broth. Acta Orthop. 77:120-124.
240. Shah, H. N., and D. M. Collins. 1990. Prevotella, a new genus to include Bacteroides melaninogenicus and related species formerly classified in the genus Bacteroides. Int. J. Syst. Bacteriol. 40:205-208.
241. Shah, H. N., and M. D. Collins. 1989. Proposal to restrict the genus Bacteroides (Castellani and Chalmers) to Bacteroides fragilis and closely related species. Int. J. Syst. Bacteriol. 39:85-87.
242. Shah, H. N., and M. D. Collins. 1988. Proposal for reclassfication of Bacteroides asaccharolyticus, Bacteroides gingivalis, and Bacteroides etulodontalis in a new genus, Porphyromonas. Int. J. Syst. Bacteriol. 38:128-131.
243. Shapiro, M. E., D. L. Kasper, D. F. Zaleznik, S. Spriggs, A. B. Onderdonk, and R. W. Finberg. 1986. Cellular control of abscess formation: role of T cells in the regulation of abscesses formed in response to Bacteroides fragilis. J. Immunol. 137:341-346.
244. Shapiro, M. E., A. B. Onderdonk, D. L. Kasper, and R. W. Finberg. 1982. Cellular immunity to Bacteroides fragilis capsular polysaccharide. J. Exp. Med. 155:1188-1197.
245. Shapiro, M. E., A. B. Onderdonk, D. L. Kasper, and R. W. Finberg. 1983. Immune T cells prevent Bacteroides fragilis abscesses. Curr. Surg. 40:123-126.
246. Shetab, R., S. H. Cohen, T. Prindiville, Y. J. Tang, M. Cantrell, D. Rahmani, and J. Silva, Jr. 1998. Detection of Bacteroides fragilis enterotoxin gene by PCR. J. Clin. Microbiol. 36:1729-1732.
247. Shipman, J. A., J. E. Berleman, and A. A. Salyers. 2000. Characterization of four outer membrane proteins involved in binding starch to the cell surface of Bacteroides thetaiotaomicron. J. Bacteriol. 182:5365-5372.
248. Shipman, J. A., K. H. Cho, H. A. Siegel, and A. A. Salyers. 1999. Physiological characterization of SusG, an outer membrane protein essential for starch utilization by Bacteroides thetaiotaomicron. J. Bacteriol. 181:7206-7211.
249. Shoemaker, N. B., R. D. Barber, and A. A. Salyers. 1989. Cloning and characterization of a Bacteroides conjugal tetracycline-erythromycin resistance element by using a shuttle eosmid vector. J. Bacteriol. 171:1294-1302.
250. Shoemaker, N. B., H. Vlamakis, K. Hayes, and A. A. Salyers. 2001. Evidence for extensive resistance gene transfer among Bacteroides spp. and among Bacteroides and other genera in the human colon. Appl. Environ. Microbiol. 67:561-568.
251. Simon, G. L., and S. L. Gorbach. 1984. Intestinal flora in health and disease. Gastroenterology 86:174-193.
252. Simon, G. L., M. S. Klempner, D. L. Kasper, and S. L. Gorbach. 1982. Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide. J. Infect. Dis. 145:72-77.
253. Smalley, D., E. R. Rocha, and C. J. Smith. 2002. Aerobic-type ribonucleotide reductase in the anaerobe Bacteroides fragilis. J. Bacteriol. 184:895-903.
254. Smith, C. J., G. D. Tribble, and D. P. Bayley. 1998. Genetic elements of Bacteroides species: a moving story. Plasmid 40:12-29.
255. Snydman, D. R., N. V. Jacobus, and L. A. McDcrmott. 2005. Evaluation of the in vitro activity of NVP-LMB415 against clinical anaerobic isolates with emphasis on the Bacteroides fragilis group. J. Antimicrob. Chemother. 55:1024-1028.
256. Snydman, D. R., N. V. Jacobus, L. A. McDermott, R. Ruthazer, Y. Golan, E. J. Goldstein, S. M. Finegold, L. J. Harrell, D. W. Hecht, S. G. Jenkins, C. Pierson, R. Venezia, V. Yu, J. Rihs, and S. L. Gorbach. 2007. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrob. Agents Chemother. 51:1649-1655.
257. Snydman, D. R., N. V. Jacobus, L. A. McDermott, R. Ruthazer, E. Goldstein, S. Finegold, L. Harrell, D. W. Hecht, S. Jenkins, C. Pierson, R. Venezia, J. Rihs, and S. L. Gorbach. 2002. In vitro activities of newer quinoloncs against Bacteroides group organisms. Antimicrob. Agents Chemother. 46:3276-3279.
258. Snydman, D. R., N. V. Jacobus, L. A. McDermott, R. Ruthazer, E. J. Goldstein, S. M. Finegold, L. J. Harrell, D. W. Hecht, S. G. Jenkins, C. Pierson, R. Venezia, J. Rihs, and S. L. Gorbach. 2002. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends for 1997-2000. Clin. Infect. Dis. 35:S126-S134.
259. Soki, J., M. Gal, J. S. Brazier, V. O. Rotimi, E. Urban, E. Nagy, and B. I. Duerden. 2006. Molecular investigation of genetic elements contributing to metronidazole resistance in Bacteroides strains. J. Antimicrob. Chemother. 57:212-220.
260. Song, Y., C. Liu, M. Bolanos, J. Lee, M. McTeague, and S. M. Finegold. 2005. Evaluation of 16S rRNA sequencing and reevaluation of a short biochemical scheme for identification of clinically significant Bacteroides species. J. Clin. Microbiol. 43:1531-1537.
261. Song, Y., C. Liu, J. Lee, M. Bolanos, M. L. Vaisanen, and S. M. Finegold. 2005. "Bacteroides goldsteinii sp. nov." isolated from clinical specimens of human intestinal origin. J. Clin. Microbiol. 43:4522-4527.
262. Song, Y. L., C. X. Liu, M. McTeague, and S. M. Finegold. 2004. "Bacteroides nordii" sp. nov. and "Bacteroides salyersae" sp. nov. isolated from clinical specimens of human intestinal origin. J. Clin. Microbiol. 42:5565-5570.
263. Sonnenburg, E. D., J. L. Sonnenburg, J. K. Manchester, E. E. Hansen, H. C. Chiang, and J. I. Gordon. 2006. A hybrid two-component system protein of a prominent human gut symbiont couples glycan sensing in vivo to carbohydrate metabolism. Proc. Natl. Acad. Sci. USA 103:8834-8839.
264. Sonnenburg, J. L., L. T. Angenent, and J. I. Gordon. 2004. Getting a grip on things: how do communities of bacterial symbionts become established in our intestine? Nat. Immunol. 5:569-573.
265. Sonnenburg, J. L., J. Xu, D. D. Leip, C. H. Chen, B. P. Westover, J. Weatherford, J. D. Buhler, and J. I. Gordon. 2005. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 307:1955-1959.
266. Stappenheck, T. S., L. V. Hooper, and J. I. Gordon. 2002. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc. Natl. Acad. Sci. USA 99:15451-15455.
267. Stellwag, E. J., and P. B. Hylemon. 1976. Purification and characterization of bile salt hydrolase from Bacteroides fragilis subsp. fragilis. Biochim. Biophys. Acta 452:165-176.
268. Stock, A. M., V. L. Robinson, and P. N. Goudreau. 2000. Two-component signal transduction. Annu. Rev. Biochem. 69:183-215.
269. Strober, W. 2006. Unraveling gut inflammation. Science 313:1052-1054.
270. Strober, W., I. Fuss, and P. Mannon. 2007. The fundamental basis of inflammatory bowel disease. J. Clin. Investig. 117:514-521.
271. Takeuchi, T., Y. Nakaya, N. Kato, K. Watanabe, and K. Morimoto. 1999. Induction of oxidative DNA damage in anaerobes. FEBS Lett. 450:178-180.
272. Talan, D. A., D. M. Citron, F. M. Abrahamian, G. J. Moran, E. J. Goldstein, et al. 1999. Bacteriologic analysis of infected dog and cat bites. N. Engl. J. Med. 340:85-92.
273. Tally, F. P., G. J. Cuchural, Jr., and M. H. Malamy. 1984. Mechanisms of resistance and resistance transfer in anaerobic bacteria: factors influencing antimicrobial therapy. Rev. Infect. Dis. 6(Suppl. 1):S260-S269.
274. Tanaka, H., F. Ito, and T. Iwasaki. 1992. Purification and characterization of a sialidase from Bacteroides fragilis SBT3182. Biochem. Biophys. Res. Commun. 189:524-529.
275. Tanaka, K., H. Mikamo, K. Nakao, and K. Watanabe. 2006. In vitro antianaerobic activity of DX-619, a new des-fluoro(6) quinolone. Antimicrob. Agents Chemother. 50:3908-3913.
276. Tancula, E., M. J. Feldhaus, L. A. Bedzyk, and A. A. Salyers. 1992. Location and characterization of genes involved in binding of starch to the surface of Bacteroides thetaiotaomicron. J. Bacteriol. 174:5609-5616.
277. Toprak, N. U., A. Yagci, B. M. Gulluoglu, M. L. Akin, P. Demirkalem, T. Celenk, and G. Soyletir. 2006. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin. Microbiol. Infect. 12:782-786.
278. Trinh, S., A. Haggoud, G. Reysset, and M. Sebald. 1995. Plasmids pIP419 and pIP421 from Bacteroides: 5-nitroimidazole resistance genes and their upstream insertion sequence elements. Microbiology 141:927-935.
279. Trinh, S., and G. Reysset. 1996. Detection by PCR of the nim genes encoding 5-nitroimidazole resistance in Bacteroides spp. J. Clin. Microbiol. 34:2078-2084.
280. Turnbaugh, P. J., R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis, and J. I. Gordon. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027-1131.
281. Tzianabos, A. O., D. L. Kasper, and A. B. Onderdonk. 1995. Structure and function of Bacteroides fragilis capsular polysaccharides: relationship to induction and prevention of abscesses. Clin. Infect. Dis. 20(Suppl. 2):S132-S140.
282. Tzianabos, A. O., A. B. Onderdonk, B. Rosner, R. L. Cisneros, and D. L. Kasper. 1993. Structural features of polysaccharides that induce intraabdominal abscesses. Science 262:416-419.
283. Tzianabos, A. O., A. Pantosti, H. Baumann, J. R. Brisson, H. J. Jennings, and D. L. Kasper. 1992. The capsular polysaccharide of Bacteroides fragilis comprises two ionically linked polysaccharides. J. Biol. Chem. 267:18230-18235.
284. Ueda, O., H. M. Wexler, K. Hirai, Y. Shibata, F. Yoshimura, and S. Fujimura. 2005. Sixteen homologs of the Mcx-type multidrug resistance efflux pump in Bacteroides fragilis. Antimicrob. Agents Chemother. 49:2807-2815.
285. University of Capetown. 11 April 2005, posting date. The enemy inside. In UCT Online-Monday paper. University of Capetown, Capetown, South Africa. http://www.news.uct.ac.za/mondaypaper/archives/?id=5053.
286. Vandamme, P., M. I. Daneshvar, F. E. Dewhirst, B. J. Paster, K. Kersters, H. Goossens, and C. W. Moss. 1995. Chemotaxonomic analyses of Bacteroides gracilis and Bacteroides ureolyticus and reclassification of B. gracilis as Campylobacter gracilis comb. nov. Int. J. Syst. Bacteriol. 45:145-152.
287. Vieira, J. M., D. C. Vallim, E. O. Ferreira, S. H. Seabra, R. C. Vommaro, K. E. Avelar, S. W. De, M. C. Ferreira, and R. M. Domingues. 2005. Bacteroides fragilis interferes with iNOS activity and leads to pore formation in macrophage surface. Biochem. Biophys. Res. Commun. 326:607-613.
288. Wang, R. C., S. J. Seror, M. Blight, J. M. Pratt, J. K. Broome-Smith, and I. B. Holland. 1991. Analysis of the membrane organization of an Escherichia coli protein translocator, HlyB, a member of a large family of prokaryote and eukaryote surface transport proteins. J. Mol. Biol. 217:441-454.
289. Wang, Y., W. M. Kalka-Moll, M. H. Roehrl, and D. L. Kasper. 2000. Structural basis of the abscess-modulating polysaccharide A2 from Bacteroides fragilis. Proc. Natl. Acad. Sci. USA 97:13478-13483.
290. Wareham, D. W., M. Wilks, D. Ahmed, J. S. Brazier, and M. Millar. 2005. Anaerobic sepsis due to multidrug-resistant Bacteroides fragilis: microbiological cure and clinical response with linezolid therapy. Clin. Infect. Dis. 40:e67-e68.
291. Weintraub, A., B. E. Larsson, and A. A. Lindberg. 1985. Chemical and immunochemical analyses of Bacteroides fragilis lipopolysaccharides. Infect. Immun. 49:197-201.
292. Weiser, J. N., and E. C. Gotschlich. 1991. Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1. Infect. Immun. 59:2252-2258.
293. Weiss, S. T. 2002. Eat dirt: the hygiene hypothesis and allergic diseases. N. Engl. J. Med. 347:930-931.
294. Welch, R. A., K. R. Jones, and F. L. Macrina. 1979. Transferable lincosamide-macrolide resistance in Bacteroides. Plasmid 2:261-268.
295. Wells, C. L., M. A. Maddaus, R. P. Jechorek, and R. L. Simmons. 1988. Role of intestinal anaerobic bacteria in colonization resistance. Eur. J. Clin. Microbiol. Infect. Dis. 7:107-113.
296. Wexler, H. M., A. E. Engel, D. Glass, and C. Li. 2005. In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates. Antimicrob. Agents Chemother. 49:4413-4417.
297. Wexler, H. M., C. Getty, and G. Fisher. 1992. The isolation and characterisation of a major outer-membrane protein from Bacteroides distasonis. J. Med. Microbiol. 37:165-175.
298. Wexler, H. M., and S. Halebian. 1990. Alterations to the penicillin-binding proteins in the Bacteroides fragilis group: a mechanism for non-β-lactamase mediated cefoxitin resistance. J. Antimicrob. Chemother. 26:7-20.
299. Wexler, H. M., E. Molitoris, D. Molitoris, and S. M. Finegold. 1998. In vitro activity of levofloxacin against a selected group of anaerobic bacteria isolated from skin and soft tissue infections. Antimicrob. Agents Chemother. 42:984-986.
300. Wexler, H. M., E. Molitoris, D. Reeves, and S. M. Finegold. 1994. In vitro activity of DU-6859a against anaerobic bacteria. Antimicrob. Agents Chemother. 38:2504-2509.
301. Wexler, H. M., E. K. Read, and T. J. Tomzynski. 2002. Characterization of omp200, a porin gene complex from Bacteroides fragilis: omp121 and omp71, gene sequence, deduced amino acid sequence and predictions of porin structure. Gene 283:95-105.
302. Wexler, H. M., E. K. Read, and T. J. Tomzynski. 2002. Identification of an OmpA protein from Bacteroides fragilis: ompA gene sequence, OmpA amino acid sequence and predictions of protein structure. Anaerobe 8:180-191.
303. Wu, S., K. C. Lim, J. Huang, R. F. Saidi, and C. L. Sears. 1998. Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc. Natl. Acad. Sci. USA 95:14979-14984.
304. Wu, S., J. Powell, N. Mathioudakis, S. Kane, E. Fernandez, and C. L. Sears. 2004. Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin-8 through mitogen-activated protein kinases and a tyrosine kinase-regulated nuclear factor-κB pathway. Infect. Immun. 72:5832-5839.
305. Wu, S., J. Shin, G. Zhang, M. Cohen, A. Franco, and C. L. Sears. 2006. The Bacteroides fragilis toxin binds to a specific intestinal epithelial cell receptor. Infect. Immun. 74:5382-5390.
306. Xu, J., M. K. Bjursell, J. Himrod, S. Deng, L. K. Carmichael, H. C. Chiang, L. V. Hooper, and J. I. Gordon. 2003. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 299:2074-2076.
307. Xu, J., H. C. Chiang, M. K. Bjursell, and J. I. Gordon. 2004. Message from a human gut symbiont: sensitivity is a prerequisite for sharing. Trends Microbiol. 12:21-28.
308. Xu, J., and J. I. Gordon. 2003. Honor thy symbionts. Proc. Natl. Acad. Sci. USA 100:10452-10459.
309. Yang, S. H., R. S. Yang, and C. L. Tsai. 2001. Septic arthritis of the hip joint in cervical cancer patients after radiotherapy: three case reports. J. Orthop. Surg. (Hong Kong) 9:41-45.
310. Zaleznik, D. F., R. W. Finberg, M. E. Shapiro, A. B. Onderdonk, and D. L. Kasper. 1985. A soluble suppressor T cell factor protects against experimental intraabdominal abscesses. J. Clin. Investig. 75:1023-1027.